scispace - formally typeset
M

Maria-Luisa Alegre

Researcher at University of Chicago

Publications -  206
Citations -  17360

Maria-Luisa Alegre is an academic researcher from University of Chicago. The author has contributed to research in topics: Transplantation & T cell. The author has an hindex of 54, co-authored 194 publications receiving 14704 citations. Previous affiliations of Maria-Luisa Alegre include University of California, San Diego & Washington University in St. Louis.

Papers
More filters
Journal ArticleDOI

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy

TL;DR: Comparison of melanoma growth in mice harboring distinct commensal microbiota and observed differences in spontaneous antitumor immunity, suggests that manipulating the microbiota may modulate cancer immunotherapy.
Journal ArticleDOI

The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients

TL;DR: The results suggest that the commensal microbiome may have a mechanistic impact on antitumor immunity in human cancer patients and could lead to improved tumor control, augmented T cell responses, and greater efficacy of anti–PD-L1 therapy.
Journal ArticleDOI

Modulation of tryptophan catabolism by regulatory T cells.

TL;DR: It is shown that mouse CD4+CD25+ cells, either resting or induced to overexpress CTLA-4 by treatment with antibody to CD3, initiated tryptophan catabolism in dendritic cells through a CT LA-4-dependent mechanism, which might represent a major mechanism of action of TR cells.
Journal ArticleDOI

STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors

TL;DR: It is found that spontaneous CD8(+) T cell priming against tumors was defective in mice lacking stimulator of interferon genes complex (STING), but not other innate signaling pathways, suggesting involvement of a cytosolic DNA sensing pathway.
Journal ArticleDOI

Serum Cytokine Levels in Human Septic Shock: Relation to Multiple-System Organ Failure and Mortality

TL;DR: TNF and IL-6 serum levels are higher in septic than in nonseptic shock, but the persistence of TNF andIL-6 in the serum rather than peak levels of cytokines predicts a poor outcome in patients with shock.